Underlying TMS clinical research and cases, Traditional TMS uses, Deep TMS advantages, and future field developments.
Dr. Doron Todder
Mental Health Hospital, Beer Sheva, Israel
Webinar covering the background of anxious depression as a condition, current treatment options, BrainsWay's clinical efficacy and Deep TMS protocol, comparisons to Figure-8 and medication studies, how to think about patient identification, and more.
Dr. Aron Tendler, MD, CBSM
Join us to discuss market access and OCD provider resources to drive demand. Other topics include best practices, evidence, coverage drivers, influencers, and more, as well as our resource center to assist with prior authorizations and appeals.
Join Key Opinion Leader (KOL) Kimberly Cress, M.D. (Greenbrook TMS NeuroHealth Centers) and BrainsWay's Chief Medical Officer, Dr. Aron Tendler to discuss the current OCD treatment landscape, BrainsWay's Deep TMS™ therapy, and a robust body of clinical evidence.
Kimberly Cress, M.D. and Aron Tendler, M.D.
Greenbrook TMS and BrainsWay
Overview and history of brain circuit mapping and modulation, TMS targeting, common brain circuit modulation, and what's next on the horizon.
Dr. Shan H. Siddiqi
Harvard Medical School
Discussing the benefits of deeper and broader stimulation using BrainsWay's innovative H-Coil technology, as well as comparisons to Figure-8 design.
Samuel Zibman, PhD